Company & Sponsor Intelligence

Cyberonics, Inc.

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials7

Recruiting0

Completed6

Countries2

Therapeutic footprint

epilepsy

Indexed studies

NCT01626599Study to Evaluate a New Device Designed to Collect Heart Activity and Body Movement Data
epilepsy · United StatesNA

NCT02385526Vagus Nerve Stimulation Titration Protocol to Improve Tolerance and Accelerate Adaptation
epilepsy · United StatesCOMPLETED

NCT01846741VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
epilepsy · United StatesNA

NCT016126893-Dimensional Accelerometer Sub-Study
epilepsy · United StatesNA

NCT00215215Effectiveness Study Comparing Treatment With Drug(s) or Adjunctive VNS Therapy for Pharmacoresistant Partial Seizures
epilepsy · United StatesPHASE4

NCT01202669Heart Rate Changes in Subjects With Epilepsy
epilepsy · United StatesCOMPLETED

NCT01325623Seizure Detection and Automatic Magnet Mode Performance Study
epilepsy · BelgiumNA

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →